ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
This article is part of the Research TopicPerspectives in Antibiotic Resistance and New Antimicrobial Drugs: 2025View all 5 articles
Study on the Antibacterial Effect of the New Anti-Biofilm Inhibitor ICAC on Escherichia coli
Provisionally accepted- 1Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences, lanzhou, China
- 2Hebei University of Engineering, Handan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The rise of bacteria antibiotics resistance has bacome increasingly severe, and the development of natural compounds with antibacterial activity represents a promising approach to combat this issue. Isochlorogenic acid C (ICAC), a phenolic acid derived from plants, was investigated in this study fou its antibacterial and antibiofilm effects against E. coli, along with the underlying mechanisms. Results revealed that ICAC exhibited significant antibacterial and antibiofilm activity against E. coli. The antibiofilm activity of ICAC against E. coli was assessed using crystal violet (CV) staining, scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM). The results demonstrated that ICAC could inhibit the biofilm formation of Escherichia coli, reduce the biomass of preformed biofilms, and decrease the production of extracellular polysaccharides (EPS) and extracellular proteins, as well as bacterial motility. Moreover, qRT-PCR results showed that ICAC downregulated genes associated with c-di-GMP synthesis while upregulating those involves in c-di-GMP degradation, thereby inhibiting biofilm formation and bacterial motility. In summary, ICAC shows potential as an effective anti-c-di-GMP agent and a novel antibacterial candidate for the treatment of E. coli infections.
Keywords: Stevia rebaudiana isochlorogenic acid C, Escherichia coli, Biofilm, EPS, motility, c-di-GMP
Received: 22 Sep 2025; Accepted: 24 Nov 2025.
Copyright: © 2025 Bai, Shang, Hu, Gao, Zhang, Li, Zhu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zhen Zhu, zhuzhen234@yeah.net
Jiyu Zhang, zhangjiyu@caas.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
